The HE4 expression is upregulated in patients with renal tissue fibrosis, and the injection of HE4 neutralizing antibody in the mouse renal disease model can inhibit renal fibrosis and delay the progression of CKD in the mice (LeBleu et al., 2013; Wan et al., 2016). Here, WFDC2 is linked to renal fibrosis.